title: Evaluation of large-scale clinical trials on cardiovascular disease risk in patients with type 2 diabetes mellitus treated with dipeptidyl peptidase 4 inhibitors and a new class of drugs.
abstract: Several recent prospective cardiovascular clinical trials completed with newly developed drugs for the treatment of type 2 diabetes mellitus have been published. Caution must be used when interpreting these studies.
authors.affiliation: Center for Diabetes, Endocrinology and Metabolism, Kansai Electric Power Hospital, Osaka, Japan.|Kansai Electric Power Medical Research Institute, Osaka, Japan.
authors.forename: Takeshi
authors.identifier: http://orcid.org/0000-0003-3713-7919
authors.initials: T
authors.lastname: Kurose
authors.affiliation: Center for Diabetes, Endocrinology and Metabolism, Kansai Electric Power Hospital, Osaka, Japan.|Kansai Electric Power Medical Research Institute, Osaka, Japan.
authors.forename: Yoshiyuki
authors.initials: Y
authors.lastname: Hamamoto
authors.affiliation: Center for Diabetes, Endocrinology and Metabolism, Kansai Electric Power Hospital, Osaka, Japan.|Kansai Electric Power Medical Research Institute, Osaka, Japan.
authors.forename: Yutaka
authors.initials: Y
authors.lastname: Seino
mesh_terms: D002318:Cardiovascular Diseases / Q000150:complications / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000627:therapeutic use*; D006801:Humans; D012307:Risk Factors; D016896:Treatment Outcome
chemical_list: D054873:Dipeptidyl-Peptidase IV Inhibitors